AVR-48

· AyuVis Research, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVR-48, covering 2025-04-06 to 2025-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Single Ascending Dose and Multiple Ascending Dose Study of AVR-48 [Phase 1]